Showing results (221-230 of 251) with videos related to

Sort By:
Pageof 26
Vascular Medicine (London, England)|October 17, 2024
Quantifying patients' preferences on tradeoffs between mortality risk and reduced need for target vessel revascularization for claudicationShelby D Reed, Jessie Sutphin, Matthew J Wallace, et al.
European Journal of Heart Failure|December 26, 2024
Empagliflozin in acute myocardial infarction in patients with and without type 2 diabetes: A pre-specified analysis of the EMPACT-MI trialMark C Petrie, Jacob A Udell, Stefan D Anker, et al.
JAMA Network Open|June 26, 2024
Concordance With Screening and Treatment Guidelines for Chronic Kidney Disease in Type 2 DiabetesDaniel Edmonston, Elizabeth Lydon, Hillary Mulder, et al.
ESC Heart Failure|September 15, 2025
Empagliflozin after myocardial infarction with or without diabetes and chronic kidney disease: Insights from EMPACT-MIFrancesco Fioretti, Javed Butler, Jacob A Udell, et al.
Pediatrics|August 4, 2025
Respiratory and Other Infections Following COVIDAndrea J Allen, Nhat Nguyen, Vitaly Lorman, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|January 26, 2018
Registry Assessment of Peripheral Interventional Devices (RAPID) - Registry Assessment of Peripheral Interventional Devices Core Data ElementsW Schuyler Jones, Mitchell W Krucoff, Pablo Morales, et al.
Journal of Vascular Surgery|February 2, 2018
Registry Assessment of Peripheral Interventional Devices (RAPID): Registry assessment of peripheral interventional devices core data elementsW Schuyler Jones, Mitchell W Krucoff, Pablo Morales, et al.
Pageof 26